Monitoring of drug safety by B. K. Romanov, S. V. Glagolev, V. A. Polivanov, M. V. Leonova

Subjects: “…drug safety, vaccine safety, individual case safety report, adverse drug reactions, adverse drug interactions…”
Get full text

Drug Safety Monitoring Information by E. V. Shubnikova, E. O. Zhuravleva, N. Yu. Velts, P. M. Giulakhmedova, A. A. Druzhinina

Get full text

International Drug Safety Monitoring by A. S. Kazakov, E. V. Shubnikova, M. A. Darmostukova, I. I. Snegireva, G. V. Kutekhova, K. E. Zatolochina, N. Yu. Velts, D. A. Kaperko, Yu. V. Olefir

Subjects: “…drug safety monitoring…”
Get full text

Drug Safety Monitoring Information by Elena V. Shubnikova, Marya A. Darmostukova, Tatyana M. Bukatina

Get full text

Defining 'surveillance' in drug safety. by Aronson, J, Hauben, M, Bate, A

Clarification of terminology in drug safety. by Aronson, J, Ferner, R

“…Nomenclature surrounding drug safety needs to be clear and unambiguous, so that patients, prescribers, manufacturers, and regulators can all understand each other. …”

Industrial guide to chemical and drug safety / by Dikshith, T. S. S., 1932-, Diwan, Prakash V.

Drug tolerability versus drug safety by Stuti Prajapati, Rachel Tao, Steven R. Feldman

Get full text

Drug Safety Monitoring—International Information by E. V. Shubnikova, T. M. Bukatina, G. V. Kutekhova

Get full text

Monitoring of Foreign Drug Safety Information by Editorial article

Get full text

An essential reference for the drug safety practitioner by Monte Andrew A

Subjects: Get full text

Effective monitoring of drug safety in the region by Shatalova O.V., Solovkina Yu.V., Gorbatenko V.S., Smuseva O.N.

“…Retrospectively notice cards of suspected adverse drug reactions received by the Volgograd regional center of drugs safety monitoring during 2010 and 2011 were analyzed. …”
Get full text

MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE by N. V. Verlan, E. O. Kochkina, N. N. Soboleva, O. A. Solodukhina

“…Hospital patients have great possibility of being infected with microorganisms, the so-called hospital strains (bacteria). The drug safety monitoring showed the necessity of the policing of prescribing of cardiovascular, antibacterial and antiglaucoma drugs.…”
Get full text

Communicating information about drug safety. by Ferner, R, Aronson, J

Observational Pharmacoepidemiology in the Drug Safety and Effectiveness Evaluation by José Cabrita, Ana Paula Martins

Get full text

The drug safety information in domestic medical literature by Ochyra Bartlomiej, Szewczyk Maciej, Przybylkowski Adam

“…Medical literature is an important source of drug safety information relevant for signal detection, safety profile analysis and risk-benefit assessment. …”
Get full text

Practical recommendations for screening of information on the drug safety by E. Yu. Pasternak, T. M. Bukatina, R. N. Alyautdin, B. K. Romanov

Subjects: Get full text

Alcohol and prescription drug safety in older adults by Zanjani F, Hoogl, AI, Downer BG

“…To address pharmacist willingness, 90 pharmacists from local pharmacies volunteered and answered questions regarding their willingness to convey prescription drug safety information to older adults.Results: Older adults reported low knowledge of alcohol and prescription drug safety, with women tending to be slightly more knowledgeable. …”
Get full text

'In silico' toxicology methods in drug safety assessment by Đukić-Ćosić Danijela, Baralić Katarina, Jorgovanović Dragica, Živančević Katarina, Javorac Dragana, Stojilković Nikola, Radović Biljana, Marić Đurđica, Ćurčić Marijana, Buha-Đorđević Aleksandra, Bulat Zorica, Antonijević-Miljaković Evica, Antonijević Biljana

“…While experimental animal investigation has historically been the most conventional approach conducted to assess drug safety and is currently considered the main method for determining drug toxicity, these studies are constricted by cost, time, and ethical approvals. …”
Get full text

Liver–Heart on chip models for drug safety by Erika Ferrari, Marco Rasponi

“…Current pre-clinical models to evaluate drug safety during the drug development process (DDP) mainly rely on traditional two-dimensional cell cultures, considered too simplistic and often ineffective, or animal experimentations, which are costly, time-consuming, and not truly representative of human responses. …”
Get full text